Investors & Media
Acceleron is a commercial-stage biopharma based in Cambridge, Massachusetts. We are guided by deep scientific expertise in the TGF-beta superfamily of biology and dedicated to the discovery and development of life-changing medicines for patients with serious and rare diseases. Our commitment to patients has led us to bring a therapy for the treatment of anemia associated with certain hematologic disorders to market in partnership with Bristol Myers Squibb and driving us toward making a lasting impact in pulmonary disease. Learn more about our clinical pipeline here.
Acceleron Pharma Inc. (NASDAQ: XLRN)
Data Provided by Refinitiv. Minimum 15 minutes delayed.